NURIX THERAPEUTICS, INC. (NRIX) /
The cash flow of NURIX THERAPEUTICS, INC. over the past 7 years
Chart NURIX THERAPEUTICS, INC.: operating cash flow, capital expenditures, free cash flow, fiscal 2019–2025 Open the chart →In fiscal 2025, the latest fiscal year on file, NURIX THERAPEUTICS, INC.'s operating cash flow was -$249.47M and its capital expenditures $14M, leaving free cash flow of -$263.47M. Free cash flow was below zero in all 7 years shown. It ranged from -$263.47M in fiscal 2025 to -$1.05M in fiscal 2019. Capital expenditures were highest in fiscal 2025, at $14M.
Year by year
| Fiscal year | Operating cash flow | Capital expenditures | Free cash flow* |
|---|---|---|---|
| 2025ended Nov 30, 2025 | -$249.47M | $14M | -$263.47M |
| 2024ended Nov 30, 2024 | -$172.58M | $9.27M | -$181.86M |
| 2023ended Nov 30, 2023 | -$81.36M | $8.4M | -$89.77M |
| 2022ended Nov 30, 2022 | -$159.81M | $12.24M | -$172.05M |
| 2021ended Nov 30, 2021 | -$84.36M | $5.66M | -$90.03M |
| 2020ended Nov 30, 2020 | -$80K | $4.55M | -$4.63M |
| 2019ended Nov 30, 2019 | $601K | $1.65M | -$1.05M |
Fiscal years as NURIX THERAPEUTICS, INC. reports them. * Calculated by us from the company's filed figures; — no figure on file. From SEC filings, updated nightly. How each line is read.
More on NURIX THERAPEUTICS, INC.
- The revenue of NURIX THERAPEUTICS, INC.
- The profitability of NURIX THERAPEUTICS, INC.
- The debt of NURIX THERAPEUTICS, INC.
- All of NURIX THERAPEUTICS, INC.'s financials, charted
Companies of a similar size
- UNFIUnited Natural Foods, Inc.
- DANDana Incorporated
- FLYFirefly Aerospace Inc.
- PTRNPattern Group Inc.
- CUBICustomers Bancorp, Inc.
Not investment advice. This page shows what NURIX THERAPEUTICS, INC. filed with the SEC. Nothing here is a recommendation about any security. Check important figures against the company's own filings.